PubRank

Effectiveness of a fixed combination formula of ombitasvir/paritaprevir/ritonavir for hepatitis C virus infection in patients on maintenance haemodialysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28621007)

Published in Nephrology (Carlton) on July 01, 2017

Authors

Norihiko Morisawa1,2, Yohei Koshima3, Satoru Kuriyama1, Momoko Matsuyama2, Naomi Hayashi1,2, Jun-Ichi Satoh2, Morimasa Amemiya2, Takashi Yokoo1

Author Affiliations

1: Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
2: Division of Nephrology, Department of Internal Medicine, Saitama Red Cross Hospital, Saitama, Japan.
3: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saitama Red Cross Hospital, Saitama, Japan.

Articles by these authors ⇆

Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study. Clin Exp Nephrol (2015) 0.80

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study. PLoS One (2015) 0.75

Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure. J Am Heart Assoc (2017) 0.75

Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital. Nephrology (Carlton) (2017) 0.75

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease. Clin Exp Nephrol (2016) 0.75